The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Facial WastingFacial Wasting
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

HAART Combos

May 20, 2004

What do u think about d4t, ddi, and kaletra as a combo? I'm concerned about the D drugs and their side affects, ie face and neuropathy

Thanks Michael

Response from Dr. Moyle

Regimens of d4T/ddI are no longer recommended based on data that suggest they may be less effective and more toxic that alternative regimens. Preferred alternative regimens include tenofovir/FTC and abacavir/3TC both of which can be given once daily. Kaletra taken as 3 pills BID is often associated with lipid, especially triglyceride, elevation and some PIs are associated with an increased relative risk of fat loss. The more compact atazanavir/ritonavir combination is just 3 pills once daily and appears more fat friendly or if you would consider an NNRTI agent, efevirenz is the one most recommended in treatment guidelines and well supported by clinical trials data.

Kind regards

Graeme Moyle

how fast does wasting occur & thoughts on regimen
Bio-Alcamid research information

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint